Navigation

Ares-Serono registers record sales

The biotechnology company, Ares-Serono, has posted strong double digit growth, with 1999 sales up 14.8 per cent. Sales have broken through the SFr1.5 billion($1 billion threshold for the first time.

This content was published on January 18, 2000 - 09:34

The biotechnology company, Ares-Serono, has posted strong double digit growth, with 1999 sales up 14.8 per cent. Sales have broken through the SFr1.5 billion($1 billion) threshold for the first time, with fourth quarter sales up more than eight per cent to a record of more than SFr430 million.

"Surpassing our goal of $1 billion in annual sales is an important milestone for Ares-Serono", said the company's CEO, Ernesto Bertarelli. "Our strong performance reflects the successful broadening of our business into new therapeutic areas of Multiple Sclerosis and AIDS wasting", he added.

Performance was especially good in North America, where sales jumped more than 20 per cent. "Our world class research combined with strategic alliances give me great confidence in our growth prospects and continuing leadership in the biotechnology sector", said Mr Bertarelli.

As well as releasing its sales figures, Ares-Serono has also announced the appointment of Jean-Pierre Verhassel as Senior Executive Vice President of Sales and Marketing. A company statement congratulated Mr Verhassel and said Ares-Serono would benefit from his marketing and sales experience as well as his management skills.

Ares-Serono is a biotechnology company headquartered in Geneva. It is the world leader in reproductive health and is also active in the field of immunolgy.

From staff and wire reports

This article was automatically imported from our old content management system. If you see any display errors, please let us know: community-feedback@swissinfo.ch

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

Share this story

Change your password

Do you really want to delete your profile?